Literature DB >> 1987673

Attenuated neuropathology by nilvadipine after middle cerebral artery occlusion in rats.

S Kawamura1, M Shirasawa, H Fukasawa, N Yasui.   

Abstract

We investigated the effects of nilvadipine, a calcium antagonist, on cerebral ischemia in rats. Under halothane anesthesia, 30 rats had a 3-0 nylon suture introduced through the extracranial internal carotid artery to occlude the left middle cerebral artery. Nilvadipine was dissolved in polyethylene glycol 400. Immediately following occlusion, group 1 rats (n = 10) were treated subcutaneously with vehicle and group 2 and 3 rats were treated with 1.0 (n = 10) and 3.2 (n = 10) mg/kg nilvadipine, respectively. Perfusion fixation was performed 24 hours later, and the histopathologic outcomes were quantified. In group 1 infarct volume was 28.2 +/- 11.4% of the total cerebral volume; in groups 2 and 3 infarct volumes were 25.5 +/- 11.6% (NS) and 13.9 +/- 9.2% (p less than 0.05 different from group 1), respectively. Nilvadipine decreased ischemic neuronal injury in a dose-dependent manner and may be of use in the treatment of cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987673     DOI: 10.1161/01.str.22.1.51

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  3 in total

1.  Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils.

Authors:  S Satoh; I Ikegaki; Y Suzuki; T Asano; M Shibuya; H Hidaka
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

Review 2.  Nilvadipine. A review of its pharmacodynamic and pharmacokinetic properties, therapeutic use in hypertension and potential in cerebrovascular disease and angina.

Authors:  R N Brogden; D McTavish
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

3.  Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat.

Authors:  J H Garcia; Y Yoshida; H Chen; Y Li; Z G Zhang; J Lian; S Chen; M Chopp
Journal:  Am J Pathol       Date:  1993-02       Impact factor: 4.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.